Ken Fisher's WST Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 21,949 shares of West Pharmaceutical Services, Inc. (WST) worth $5.76 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in WST, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 77,248 shares. Largest reduction occurred in Q2 2020, reducing 221,137 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +1.32 M | Add 0.00% | 1.32 M | $35.13 |
| Q3 2013 | -43,580 | Reduce 3.30% | 1.28 M | $41.15 |
| Q4 2013 | -32,825 | Reduce 2.57% | 1.24 M | $49.06 |
| Q1 2014 | -13,540 | Reduce 1.09% | 1.23 M | $44.05 |
| Q2 2014 | +77,248 | Add 6.29% | 1.31 M | $42.18 |
| Q3 2014 | -40,249 | Reduce 3.08% | 1.27 M | $44.76 |
| Q4 2014 | +54,520 | Add 4.31% | 1.32 M | $53.24 |
| Q1 2015 | -10,075 | Reduce 0.76% | 1.31 M | $60.21 |
| Q2 2015 | -18,275 | Reduce 1.39% | 1.29 M | $58.08 |
| Q3 2015 | -43,094 | Reduce 3.33% | 1.25 M | $54.12 |
| Q4 2015 | -8,955 | Reduce 0.72% | 1.24 M | $60.22 |
| Q1 2016 | -11,790 | Reduce 0.95% | 1.23 M | $71.30 |
| Q2 2016 | +7,487 | Add 0.61% | 1.24 M | $77.73 |
| Q3 2016 | -13,388 | Reduce 1.08% | 1.22 M | $74.50 |
| Q4 2016 | -51,831 | Reduce 4.24% | 1.17 M | $84.83 |
| Q1 2017 | -46,422 | Reduce 3.97% | 1.12 M | $81.61 |
| Q2 2017 | -25,050 | Reduce 2.23% | 1.1 M | $94.52 |
| Q3 2017 | -36,855 | Reduce 3.35% | 1.06 M | $96.26 |
| Q4 2017 | -14,669 | Reduce 1.38% | 1.05 M | $98.67 |
| Q1 2018 | -63,384 | Reduce 6.05% | 984,251 | $88.29 |
| Q2 2018 | -9,047 | Reduce 0.92% | 975,204 | $99.29 |
| Q3 2018 | -52,703 | Reduce 5.40% | 922,501 | $123.47 |
| Q4 2018 | +2,463 | Add 0.27% | 924,964 | $98.03 |
| Q1 2019 | -18,223 | Reduce 1.97% | 906,741 | $110.20 |
| Q2 2019 | -1,523 | Reduce 0.17% | 905,218 | $125.15 |
| Q3 2019 | -10,068 | Reduce 1.11% | 895,150 | $141.82 |
| Q4 2019 | -170,577 | Reduce 19.06% | 724,573 | $150.33 |
| Q1 2020 | -75,812 | Reduce 10.46% | 648,761 | $152.25 |
| Q2 2020 | -221,137 | Reduce 34.09% | 427,624 | $227.17 |
| Q3 2020 | -112,641 | Reduce 26.34% | 314,983 | $274.90 |
| Q4 2020 | +2,004 | Add 0.64% | 316,987 | $283.31 |
| Q1 2021 | -8,159 | Reduce 2.57% | 308,828 | $281.78 |
| Q2 2021 | -21,086 | Reduce 6.83% | 287,742 | $359.10 |
| Q3 2021 | -4,624 | Reduce 1.61% | 283,118 | $424.54 |
| Q4 2021 | -15,048 | Reduce 5.32% | 268,070 | $469.01 |
| Q1 2022 | -3,193 | Reduce 1.19% | 264,877 | $410.71 |
| Q2 2022 | -8,007 | Reduce 3.02% | 256,870 | $302.37 |
| Q3 2022 | -93,685 | Reduce 36.47% | 163,185 | $246.08 |
| Q4 2022 | -62,784 | Reduce 38.47% | 100,401 | $235.36 |
| Q1 2023 | -63,050 | Reduce 62.80% | 37,351 | $346.47 |
| Q2 2023 | -84 | Reduce 0.22% | 37,267 | $382.47 |
| Q3 2023 | -8,000 | Reduce 21.47% | 29,267 | $375.21 |
| Q4 2023 | -659 | Reduce 2.25% | 28,608 | $352.13 |
| Q1 2024 | +118 | Add 0.41% | 28,726 | $395.72 |
| Q2 2024 | +48 | Add 0.17% | 28,774 | $329.40 |
| Q3 2024 | -34 | Reduce 0.12% | 28,740 | $300.17 |
| Q4 2024 | +2 | Add 0.01% | 28,742 | $327.57 |
| Q1 2025 | +579 | Add 2.01% | 29,321 | $223.88 |
| Q2 2025 | -4,983 | Reduce 16.99% | 24,338 | $218.81 |
| Q3 2025 | -2,389 | Reduce 9.82% | 21,949 | $262.34 |
Ken Fisher's West Pharmaceutical Services Investment FAQs
Ken Fisher first purchased West Pharmaceutical Services, Inc. (WST) in Q2 2013, acquiring 1,318,978 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held West Pharmaceutical Services, Inc. (WST) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q2 2013, adding 1,318,978 shares worth $46.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 21,949 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $5.76 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in West Pharmaceutical Services, Inc. (WST) was 1,320,552 shares, as reported at the end of Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.